Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?

Page 1 of 2

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is currently trading higher by 13% after having its price target raised to $90 by Canaccord – which is now the highest target on the stock. The stock is trading at $68.50 after a one-year 380% gain due to the recent FDA approval of its drug Juxtapid. However, I believe the stock has gotten ahead of itself, and that there is no basis for a $90 price target.

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Reflection of Previous Analysis

Back on May 19, I wrote an article on Aegerion called “Too Many Questions Make This Thursday Mover A Sell.” Basically, the article walks the reader through all of the speculation that has created its large movement; including the company’s misleading statements regarding Juxtapid’s potential.

Juxtapid will be used to treat homozygous familial hypercholesterolemia. However, “rare cholesterol disease” is much easier when discussing the disease. My first article showed how the patient population for this disease is very scattered, as the company indicates it to be one size (3,000 total domestically) while the FDA estimates it to be significantly smaller (just 315 annual claims).

My conclusion from the previous article is that the true number of “rare cholesterol disease” is somewhere in the middle. When considering that there is already a drug on the market, Sanofi’s Kynamro, to treat the exact same condition I predicted peak sales to be $250 million for Juxtapid – which I believe is vital to assessing and valuing the company.

Valuing Biotechnology By Peak Sales

When I predict $250 million in peak sales – I mean just that – it is “peak sales” and very few drugs ever reach full potential.

With that said, I find Canaccord’s $90 price target very hard to assess. I immediately wondered, “What metric are they using?” According to Canaccord, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) will reach a market capitalization of $2.60 billion, which means that it’s currently trading at about 10 times peak sales potential.

When a biotechnology company has a newly approved product, the only way to accurately assess its outlook is by sales potential. At this point for Aegerion, there is no way to know Juxtapid’s eventual operating margins or how long it will take for the company to reach peak sales. Therefore, high-profile newly launched products and hyper-growth pharmaceutical companies are often valued based on their potential, or a lead product’s peak sales potential.

A Side-By-Side Comparison

If Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)’s $90 price target is based on the peak sales of Juxtapid then Aegerion is one of the most expensive stocks in the biotechnology arena. With that said, I want to compare Canaccord’s target and Aegerion’s price/peak sales potential to that of other high-profile biotechnology companies.

Company Ticker Price Target* Firm Lead Drug Peak Sales (millions) Target Valuation/Peak Sales Potential**
Aegerion Pharmaceuticals AEGR $90 Canaccord Juxtapid $250 10.37
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) $315 Brean Capital EYLEA $4,000 7.71
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) $132 Canaccord Soliris $5,000 5.15
Sarepta Therapeutics Inc (NASDAQ:SRPT) $63 Baird Eteplirsen $700 2.86

*top price target of all analyst outlooks

** Determined by multiplying price target by shares outstanding to find targeted market cap. The market cap is then dividend by the estimated peak sales potential.

For the most part, the drug that has the greatest sales potential also warrants the higher target valuation/peak sales ratio. There are only two exceptions.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

The 10 Biggest Outlet Malls in USA

The 5 Most Popular Rap Songs of All Time

The 10 Countries that Eat the Most Meat

The10 Most Expensive Countries to Fly To

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!